Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thijn Brummelkamp Receives the EMBO Gold Medal for 2013

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
The award acknowledges his outstanding work to accelerate the genetic analysis of human disease.

In 2002, Brummelkamp developed an inexpensive method to permanently inactivate large numbers of genes by the use of RNA interference. This breakthrough involved the development of a new short hairpin RNA vector system (pSUPER) that directs the synthesis of small interfering RNAs in mammalian cells. The method is used today in many laboratories throughout the world and allows researchers to collect detailed information on the function and roles of the many human genes involved in diseases like cancer. The paper by Brummelkamp and colleagues in Science that describes the method has been cited more than 3500 times according to Thomson Reuters Web of Knowledge.

Brummelkamp and his research group also investigate how viruses and bacteria make their way into mammalian cells. The development of haploid genetic screens in Brummelkamp’s laboratory has permitted the identification of some of the proteins required for the entry of pathogens into mammalian cells. This method was recently used to demonstrate that the entry of the Ebola virus into human cells requires a protein involved in the transport of cholesterol. This type of work helps to identify new drug targets and is opening up novel approaches and strategies for the treatment of different viral and bacterial diseases.

“I am delighted and honoured to receive such a prestigious award and extremely grateful that I have been able to work with many fantastic scientists in stimulating environments over the years,” the prizewinner said upon hearing the news.

“Thijn Brummelkamp belongs to a rare breed of scientists that can influence a field of research not once but repeatedly,” commented Anton Berns, former director of research at the NKI. “He is expected to make many additional landmark contributions to molecular biology in the years to come,” stated EMBO Member Piet Borst from the NKI in his nomination letter.

In 2005, Brummelkamp was selected as one of the top innovators under the age of 35 in the United States by MIT Technology Review magazine.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Small Non-coding RNAs Could be Warning Signs of Cancer
Results are published in EMBO reports.
Tuesday, February 18, 2014
Cancer Stem Cells Isolated from Kidney Tumours
Scientists have isolated cancer stem cells that lead to the growth of Wilms’ tumours, a type of cancer typically found in the kidneys of young children.
Friday, December 14, 2012
EMBO, EMBC and the National Science Council of Taiwan Sign Cooperation Agreement
New ways of global scientific interaction have been created following a cooperation agreement between EMBO, the European Molecular Biology Conference (EMBC), and the National Science Council of Taiwan (NSC).
Thursday, November 29, 2012
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!